1. European Urology Oncology
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study 
Petros Grivas, Aly-Khan A. Lalani, Gregory R. Pond, Rebecca J. Nagy, Bishoy Faltas, Neeraj Agarwal, Sumati V. Gupta, Alexandra Drakaki, Ulka N. Vaishampayan, Jue Wang, Pedro C. Barata, Dharmesh Gopalakrishnan, Gurudatta Naik, Bradley A. McGregor, Lesli A. Kiedrowski, Richard B. Lanman, Guru P. Sonpavde 
European Urology Oncology 
DOI: /j.euo
Copyright © 2019 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier curves for failure-free survival (FFS) and overall survival (OS) for patients with advanced urothelial carcinoma harboring alterations in (A, C) BRCA1 or (B, D) RAF1. HR=hazard ratio.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2019 European Association of Urology Terms and Conditions